2235 Stock Overview
MicroTech Medical (Hangzhou) Co., Ltd. engages in the research and development, manufacture, and commercialization of diabetes management medical devices and consumables in the People’s Republic of China and internationally.
No risks detected for 2235 from our risk checks.
MicroTech Medical (Hangzhou) Co., Ltd. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||HK$7.25|
|52 Week High||HK$31.70|
|52 Week Low||HK$6.28|
|1 Month Change||-7.17%|
|3 Month Change||-26.77%|
|1 Year Change||n/a|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-76.23%|
Recent News & Updates
|2235||HK Medical Equipment||HK Market|
Return vs Industry: Insufficient data to determine how 2235 performed against the Hong Kong Medical Equipment industry.
Return vs Market: Insufficient data to determine how 2235 performed against the Hong Kong Market.
|2235 Average Weekly Movement||4.5%|
|Medical Equipment Industry Average Movement||7.1%|
|Market Average Movement||6.4%|
|10% most volatile stocks in HK Market||12.6%|
|10% least volatile stocks in HK Market||3.1%|
Stable Share Price: 2235 is not significantly more volatile than the rest of Hong Kong stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: 2235's weekly volatility (5%) has been stable over the past year.
About the Company
MicroTech Medical (Hangzhou) Co., Ltd. engages in the research and development, manufacture, and commercialization of diabetes management medical devices and consumables in the People’s Republic of China and internationally. Its products include Equil Patch insulin pump systems, AiDEX continuous glucose monitoring systems, POCT analyzer systems, blood glucose monitoring systems, and closed-loop artificial pancreas. The company is also involved in engineering and technology research experimentation and development activities.
MicroTech Medical (Hangzhou) Co., Ltd. Fundamentals Summary
|2235 fundamental statistics|
Is 2235 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|2235 income statement (TTM)|
|Cost of Revenue||CN¥92.67m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.087|
|Net Profit Margin||-22.61%|
How did 2235 perform over the long term?See historical performance and comparison